Ronan Kelly
Medical Oncology · Dallas, TXNPI 1477846715
Payments from drug & device makers
Across 643 payments — averaging $3516.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$645K
- Eli Lilly$567K
- AstraZeneca$154K
- Exact Sciences$136K
- Astellas Pharma US Inc$132K
- Daiichi Sankyo Inc.$120K
- plus $507K from 23 others
Across 4 payments — averaging $16,740 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Macrogenics, Inc.$47K
- Eli Lilly$20K
What the payments were for
- Consulting fees$473,71343%
- Speaking & faculty fees$481,70744%
- Travel & lodging$126,47212%
- Food & beverage$9,1601%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 218 | $644,633 |
| Eli Lilly | 3 | $567,274 |
| AstraZeneca | 38 | $153,595 |
| Exact Sciences | 20 | $135,964 |
| Astellas Pharma US Inc | 81 | $132,460 |
| Daiichi Sankyo Inc. | 63 | $119,895 |
| Merck | 33 | $106,400 |
| Beone Medicines USA, Inc. | 62 | $102,957 |
| Novartis | 13 | $48,630 |
| Macrogenics, Inc. | 12 | $45,303 |
| Iovance Biotherapeutics, Inc. | 24 | $42,270 |
| Caris MPI, Inc. | 1 | $38,415 |
| GSK | 5 | $29,833 |
| Astrazeneca UK Limited | 5 | $14,566 |
| EMD Serono, Inc. | 4 | $13,000 |
| Gilead | 4 | $11,170 |
| Beigene USA, Inc. | 8 | $9,090 |
| Lilly USA, LLC | 9 | $7,554 |
| Amgen | 5 | $6,860 |
| Novocure Inc. | 2 | $6,742 |
| Ipsen Biopharmaceuticals, Inc | 1 | $6,200 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $5,610 |
| Eisai Inc. | 2 | $4,080 |
| Astellas Pharma Global Development | 13 | $3,419 |
| Jazz Pharmaceuticals Inc. | 1 | $3,098 |
| US Endoscopy | 4 | $1,725 |
| AbbVie | 4 | $65 |
| Siemens Medical Solutions USA, Inc. | 4 | $60 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,260,881 in reported general payments places this provider in the 80th percentile of 495 medical oncology providers in Texas.
Other medical oncology in Dallas
- Sawsan RashdanDallas$29.9M
- David GerberDallas$22.8M
- Joyce O'ShaughnessyDallas$20.8M
- Moshe LevyDallas$19.7M
- Minal BarveDallas$16.7M
- Andrew PaulsonDallas$11.5M
- Hans HammersDallas$11.4M
- James StraussDallas$9.1M
- Larry AndersonDallas$8.7M
- Heather McArthurDallas$7.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.